nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiagabine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.132	0.248	CbGbCtD
Tiagabine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0998	0.188	CbGbCtD
Tiagabine—CYP3A4—Betamethasone—ankylosing spondylitis	0.0856	0.161	CbGbCtD
Tiagabine—CYP3A4—Prednisolone—ankylosing spondylitis	0.0845	0.159	CbGbCtD
Tiagabine—CYP3A4—Prednisone—ankylosing spondylitis	0.0798	0.15	CbGbCtD
Tiagabine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0498	0.0938	CbGbCtD
Tiagabine—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000615	0.00131	CcSEcCtD
Tiagabine—Shock—Prednisolone—ankylosing spondylitis	0.000613	0.00131	CcSEcCtD
Tiagabine—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.000612	0.00131	CcSEcCtD
Tiagabine—Cough—Triamcinolone—ankylosing spondylitis	0.000612	0.00131	CcSEcCtD
Tiagabine—Tachycardia—Prednisolone—ankylosing spondylitis	0.000608	0.0013	CcSEcCtD
Tiagabine—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.000607	0.00129	CcSEcCtD
Tiagabine—Hypertension—Triamcinolone—ankylosing spondylitis	0.000606	0.00129	CcSEcCtD
Tiagabine—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000604	0.00129	CcSEcCtD
Tiagabine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000602	0.00128	CcSEcCtD
Tiagabine—Myalgia—Triamcinolone—ankylosing spondylitis	0.000597	0.00127	CcSEcCtD
Tiagabine—Pneumonia—Methotrexate—ankylosing spondylitis	0.000596	0.00127	CcSEcCtD
Tiagabine—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000596	0.00127	CcSEcCtD
Tiagabine—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000596	0.00127	CcSEcCtD
Tiagabine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000594	0.00127	CcSEcCtD
Tiagabine—Depression—Methotrexate—ankylosing spondylitis	0.000591	0.00126	CcSEcCtD
Tiagabine—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000591	0.00126	CcSEcCtD
Tiagabine—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000591	0.00126	CcSEcCtD
Tiagabine—Discomfort—Triamcinolone—ankylosing spondylitis	0.00059	0.00126	CcSEcCtD
Tiagabine—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000589	0.00126	CcSEcCtD
Tiagabine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000584	0.00125	CcSEcCtD
Tiagabine—Renal failure—Methotrexate—ankylosing spondylitis	0.000583	0.00124	CcSEcCtD
Tiagabine—Stomatitis—Methotrexate—ankylosing spondylitis	0.000578	0.00123	CcSEcCtD
Tiagabine—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000576	0.00123	CcSEcCtD
Tiagabine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000576	0.00123	CcSEcCtD
Tiagabine—Malaise—Betamethasone—ankylosing spondylitis	0.000574	0.00122	CcSEcCtD
Tiagabine—Malaise—Dexamethasone—ankylosing spondylitis	0.000574	0.00122	CcSEcCtD
Tiagabine—Oedema—Triamcinolone—ankylosing spondylitis	0.000573	0.00122	CcSEcCtD
Tiagabine—Vertigo—Dexamethasone—ankylosing spondylitis	0.000572	0.00122	CcSEcCtD
Tiagabine—Vertigo—Betamethasone—ankylosing spondylitis	0.000572	0.00122	CcSEcCtD
Tiagabine—Syncope—Dexamethasone—ankylosing spondylitis	0.000571	0.00122	CcSEcCtD
Tiagabine—Syncope—Betamethasone—ankylosing spondylitis	0.000571	0.00122	CcSEcCtD
Tiagabine—Infection—Triamcinolone—ankylosing spondylitis	0.000569	0.00121	CcSEcCtD
Tiagabine—Sweating—Methotrexate—ankylosing spondylitis	0.000568	0.00121	CcSEcCtD
Tiagabine—Infection—Methylprednisolone—ankylosing spondylitis	0.000568	0.00121	CcSEcCtD
Tiagabine—Haematuria—Methotrexate—ankylosing spondylitis	0.000565	0.00121	CcSEcCtD
Tiagabine—Shock—Triamcinolone—ankylosing spondylitis	0.000563	0.0012	CcSEcCtD
Tiagabine—Insomnia—Prednisolone—ankylosing spondylitis	0.000563	0.0012	CcSEcCtD
Tiagabine—Alopecia—Prednisone—ankylosing spondylitis	0.000563	0.0012	CcSEcCtD
Tiagabine—Shock—Methylprednisolone—ankylosing spondylitis	0.000562	0.0012	CcSEcCtD
Tiagabine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000559	0.00119	CcSEcCtD
Tiagabine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000559	0.00119	CcSEcCtD
Tiagabine—Epistaxis—Methotrexate—ankylosing spondylitis	0.000559	0.00119	CcSEcCtD
Tiagabine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000559	0.00119	CcSEcCtD
Tiagabine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000559	0.00119	CcSEcCtD
Tiagabine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000558	0.00119	CcSEcCtD
Tiagabine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000553	0.00118	CcSEcCtD
Tiagabine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000552	0.00118	CcSEcCtD
Tiagabine—Hypertension—Dexamethasone—ankylosing spondylitis	0.00055	0.00117	CcSEcCtD
Tiagabine—Hypertension—Betamethasone—ankylosing spondylitis	0.00055	0.00117	CcSEcCtD
Tiagabine—Myalgia—Dexamethasone—ankylosing spondylitis	0.000542	0.00116	CcSEcCtD
Tiagabine—Myalgia—Betamethasone—ankylosing spondylitis	0.000542	0.00116	CcSEcCtD
Tiagabine—Anxiety—Betamethasone—ankylosing spondylitis	0.00054	0.00115	CcSEcCtD
Tiagabine—Anxiety—Dexamethasone—ankylosing spondylitis	0.00054	0.00115	CcSEcCtD
Tiagabine—Discomfort—Dexamethasone—ankylosing spondylitis	0.000535	0.00114	CcSEcCtD
Tiagabine—Discomfort—Betamethasone—ankylosing spondylitis	0.000535	0.00114	CcSEcCtD
Tiagabine—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000535	0.00114	CcSEcCtD
Tiagabine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000534	0.00114	CcSEcCtD
Tiagabine—Pain—Prednisolone—ankylosing spondylitis	0.000532	0.00114	CcSEcCtD
Tiagabine—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000532	0.00114	CcSEcCtD
Tiagabine—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000528	0.00113	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000522	0.00111	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00052	0.00111	CcSEcCtD
Tiagabine—Oedema—Dexamethasone—ankylosing spondylitis	0.000519	0.00111	CcSEcCtD
Tiagabine—Oedema—Betamethasone—ankylosing spondylitis	0.000519	0.00111	CcSEcCtD
Tiagabine—Insomnia—Triamcinolone—ankylosing spondylitis	0.000518	0.0011	CcSEcCtD
Tiagabine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000517	0.0011	CcSEcCtD
Tiagabine—Infection—Dexamethasone—ankylosing spondylitis	0.000516	0.0011	CcSEcCtD
Tiagabine—Infection—Betamethasone—ankylosing spondylitis	0.000516	0.0011	CcSEcCtD
Tiagabine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000514	0.0011	CcSEcCtD
Tiagabine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000514	0.0011	CcSEcCtD
Tiagabine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000513	0.00109	CcSEcCtD
Tiagabine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000513	0.00109	CcSEcCtD
Tiagabine—Visual impairment—Methotrexate—ankylosing spondylitis	0.000513	0.00109	CcSEcCtD
Tiagabine—Anaemia—Prednisone—ankylosing spondylitis	0.000512	0.00109	CcSEcCtD
Tiagabine—Shock—Dexamethasone—ankylosing spondylitis	0.000511	0.00109	CcSEcCtD
Tiagabine—Shock—Betamethasone—ankylosing spondylitis	0.000511	0.00109	CcSEcCtD
Tiagabine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00051	0.00109	CcSEcCtD
Tiagabine—Agitation—Prednisone—ankylosing spondylitis	0.000509	0.00109	CcSEcCtD
Tiagabine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000509	0.00108	CcSEcCtD
Tiagabine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000509	0.00108	CcSEcCtD
Tiagabine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000507	0.00108	CcSEcCtD
Tiagabine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000507	0.00108	CcSEcCtD
Tiagabine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000504	0.00107	CcSEcCtD
Tiagabine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000503	0.00107	CcSEcCtD
Tiagabine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000502	0.00107	CcSEcCtD
Tiagabine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000502	0.00107	CcSEcCtD
Tiagabine—Malaise—Prednisone—ankylosing spondylitis	0.0005	0.00107	CcSEcCtD
Tiagabine—Vertigo—Prednisone—ankylosing spondylitis	0.000498	0.00106	CcSEcCtD
Tiagabine—Syncope—Prednisone—ankylosing spondylitis	0.000497	0.00106	CcSEcCtD
Tiagabine—Tinnitus—Methotrexate—ankylosing spondylitis	0.000496	0.00106	CcSEcCtD
Tiagabine—Anorexia—Dexamethasone—ankylosing spondylitis	0.000495	0.00106	CcSEcCtD
Tiagabine—Anorexia—Betamethasone—ankylosing spondylitis	0.000495	0.00106	CcSEcCtD
Tiagabine—Urticaria—Prednisolone—ankylosing spondylitis	0.000495	0.00105	CcSEcCtD
Tiagabine—Fatigue—Triamcinolone—ankylosing spondylitis	0.000494	0.00105	CcSEcCtD
Tiagabine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000493	0.00105	CcSEcCtD
Tiagabine—Pain—Triamcinolone—ankylosing spondylitis	0.00049	0.00104	CcSEcCtD
Tiagabine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000487	0.00104	CcSEcCtD
Tiagabine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000485	0.00104	CcSEcCtD
Tiagabine—Hypotension—Betamethasone—ankylosing spondylitis	0.000485	0.00104	CcSEcCtD
Tiagabine—Hypertension—Prednisone—ankylosing spondylitis	0.000479	0.00102	CcSEcCtD
Tiagabine—Chills—Methotrexate—ankylosing spondylitis	0.000477	0.00102	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000473	0.00101	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000473	0.00101	CcSEcCtD
Tiagabine—Myalgia—Prednisone—ankylosing spondylitis	0.000472	0.00101	CcSEcCtD
Tiagabine—Arthralgia—Prednisone—ankylosing spondylitis	0.000472	0.00101	CcSEcCtD
Tiagabine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000472	0.00101	CcSEcCtD
Tiagabine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000471	0.001	CcSEcCtD
Tiagabine—Anxiety—Prednisone—ankylosing spondylitis	0.00047	0.001	CcSEcCtD
Tiagabine—Alopecia—Methotrexate—ankylosing spondylitis	0.00047	0.001	CcSEcCtD
Tiagabine—Insomnia—Betamethasone—ankylosing spondylitis	0.00047	0.001	CcSEcCtD
Tiagabine—Insomnia—Dexamethasone—ankylosing spondylitis	0.00047	0.001	CcSEcCtD
Tiagabine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000467	0.000996	CcSEcCtD
Tiagabine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000466	0.000995	CcSEcCtD
Tiagabine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000466	0.000995	CcSEcCtD
Tiagabine—Discomfort—Prednisone—ankylosing spondylitis	0.000466	0.000995	CcSEcCtD
Tiagabine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000459	0.000978	CcSEcCtD
Tiagabine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000457	0.000975	CcSEcCtD
Tiagabine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000457	0.000975	CcSEcCtD
Tiagabine—Urticaria—Triamcinolone—ankylosing spondylitis	0.000455	0.00097	CcSEcCtD
Tiagabine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000454	0.000968	CcSEcCtD
Tiagabine—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000454	0.000968	CcSEcCtD
Tiagabine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000453	0.000965	CcSEcCtD
Tiagabine—Oedema—Prednisone—ankylosing spondylitis	0.000452	0.000965	CcSEcCtD
Tiagabine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000452	0.000963	CcSEcCtD
Tiagabine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000452	0.000963	CcSEcCtD
Tiagabine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000452	0.000963	CcSEcCtD
Tiagabine—Infection—Prednisone—ankylosing spondylitis	0.000449	0.000959	CcSEcCtD
Tiagabine—Back pain—Methotrexate—ankylosing spondylitis	0.000448	0.000956	CcSEcCtD
Tiagabine—Fatigue—Dexamethasone—ankylosing spondylitis	0.000448	0.000955	CcSEcCtD
Tiagabine—Fatigue—Betamethasone—ankylosing spondylitis	0.000448	0.000955	CcSEcCtD
Tiagabine—Shock—Prednisone—ankylosing spondylitis	0.000445	0.000949	CcSEcCtD
Tiagabine—Pain—Betamethasone—ankylosing spondylitis	0.000444	0.000948	CcSEcCtD
Tiagabine—Pain—Dexamethasone—ankylosing spondylitis	0.000444	0.000948	CcSEcCtD
Tiagabine—Tachycardia—Prednisone—ankylosing spondylitis	0.000442	0.000942	CcSEcCtD
Tiagabine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000437	0.000933	CcSEcCtD
Tiagabine—Anorexia—Prednisone—ankylosing spondylitis	0.000431	0.00092	CcSEcCtD
Tiagabine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00043	0.000917	CcSEcCtD
Tiagabine—Anaemia—Methotrexate—ankylosing spondylitis	0.000428	0.000913	CcSEcCtD
Tiagabine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000428	0.000913	CcSEcCtD
Tiagabine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000428	0.000913	CcSEcCtD
Tiagabine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000425	0.000906	CcSEcCtD
Tiagabine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000425	0.000906	CcSEcCtD
Tiagabine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000422	0.0009	CcSEcCtD
Tiagabine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000421	0.000898	CcSEcCtD
Tiagabine—Malaise—Methotrexate—ankylosing spondylitis	0.000418	0.000891	CcSEcCtD
Tiagabine—Vertigo—Methotrexate—ankylosing spondylitis	0.000416	0.000888	CcSEcCtD
Tiagabine—Leukopenia—Methotrexate—ankylosing spondylitis	0.000415	0.000884	CcSEcCtD
Tiagabine—Urticaria—Dexamethasone—ankylosing spondylitis	0.000413	0.00088	CcSEcCtD
Tiagabine—Urticaria—Betamethasone—ankylosing spondylitis	0.000413	0.00088	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000412	0.000879	CcSEcCtD
Tiagabine—Dizziness—Prednisolone—ankylosing spondylitis	0.000412	0.000878	CcSEcCtD
Tiagabine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000411	0.000876	CcSEcCtD
Tiagabine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000411	0.000876	CcSEcCtD
Tiagabine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000411	0.000876	CcSEcCtD
Tiagabine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000411	0.000876	CcSEcCtD
Tiagabine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000411	0.000876	CcSEcCtD
Tiagabine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00041	0.000874	CcSEcCtD
Tiagabine—Insomnia—Prednisone—ankylosing spondylitis	0.000409	0.000873	CcSEcCtD
Tiagabine—Paraesthesia—Prednisone—ankylosing spondylitis	0.000406	0.000866	CcSEcCtD
Tiagabine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000405	0.000864	CcSEcCtD
Tiagabine—Cough—Methotrexate—ankylosing spondylitis	0.000404	0.000862	CcSEcCtD
Tiagabine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000404	0.000862	CcSEcCtD
Tiagabine—Dyspepsia—Prednisone—ankylosing spondylitis	0.000398	0.000849	CcSEcCtD
Tiagabine—Arthralgia—Methotrexate—ankylosing spondylitis	0.000394	0.000841	CcSEcCtD
Tiagabine—Chest pain—Methotrexate—ankylosing spondylitis	0.000394	0.000841	CcSEcCtD
Tiagabine—Myalgia—Methotrexate—ankylosing spondylitis	0.000394	0.000841	CcSEcCtD
Tiagabine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000393	0.000839	CcSEcCtD
Tiagabine—Rash—Prednisolone—ankylosing spondylitis	0.000393	0.000837	CcSEcCtD
Tiagabine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000392	0.000836	CcSEcCtD
Tiagabine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000391	0.000834	CcSEcCtD
Tiagabine—Fatigue—Prednisone—ankylosing spondylitis	0.00039	0.000832	CcSEcCtD
Tiagabine—Headache—Prednisolone—ankylosing spondylitis	0.00039	0.000832	CcSEcCtD
Tiagabine—Discomfort—Methotrexate—ankylosing spondylitis	0.00039	0.000831	CcSEcCtD
Tiagabine—Constipation—Prednisone—ankylosing spondylitis	0.000387	0.000825	CcSEcCtD
Tiagabine—Confusional state—Methotrexate—ankylosing spondylitis	0.000381	0.000813	CcSEcCtD
Tiagabine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000379	0.000808	CcSEcCtD
Tiagabine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000378	0.000806	CcSEcCtD
Tiagabine—Infection—Methotrexate—ankylosing spondylitis	0.000376	0.000801	CcSEcCtD
Tiagabine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000373	0.000795	CcSEcCtD
Tiagabine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000373	0.000795	CcSEcCtD
Tiagabine—Asthenia—Betamethasone—ankylosing spondylitis	0.000373	0.000795	CcSEcCtD
Tiagabine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00037	0.00079	CcSEcCtD
Tiagabine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00037	0.000789	CcSEcCtD
Tiagabine—Nausea—Prednisolone—ankylosing spondylitis	0.00037	0.000789	CcSEcCtD
Tiagabine—Pruritus—Betamethasone—ankylosing spondylitis	0.000368	0.000784	CcSEcCtD
Tiagabine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000368	0.000784	CcSEcCtD
Tiagabine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000366	0.00078	CcSEcCtD
Tiagabine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000364	0.000776	CcSEcCtD
Tiagabine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000363	0.000775	CcSEcCtD
Tiagabine—Rash—Triamcinolone—ankylosing spondylitis	0.000361	0.00077	CcSEcCtD
Tiagabine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000361	0.000769	CcSEcCtD
Tiagabine—Anorexia—Methotrexate—ankylosing spondylitis	0.00036	0.000769	CcSEcCtD
Tiagabine—Rash—Methylprednisolone—ankylosing spondylitis	0.00036	0.000768	CcSEcCtD
Tiagabine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00036	0.000768	CcSEcCtD
Tiagabine—Urticaria—Prednisone—ankylosing spondylitis	0.000359	0.000767	CcSEcCtD
Tiagabine—Headache—Triamcinolone—ankylosing spondylitis	0.000359	0.000765	CcSEcCtD
Tiagabine—Headache—Methylprednisolone—ankylosing spondylitis	0.000358	0.000763	CcSEcCtD
Tiagabine—Abdominal pain—Prednisone—ankylosing spondylitis	0.000358	0.000763	CcSEcCtD
Tiagabine—Body temperature increased—Prednisone—ankylosing spondylitis	0.000358	0.000763	CcSEcCtD
Tiagabine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000355	0.000758	CcSEcCtD
Tiagabine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000355	0.000758	CcSEcCtD
Tiagabine—Hypotension—Methotrexate—ankylosing spondylitis	0.000353	0.000754	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000344	0.000735	CcSEcCtD
Tiagabine—Dizziness—Betamethasone—ankylosing spondylitis	0.000344	0.000733	CcSEcCtD
Tiagabine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000344	0.000733	CcSEcCtD
Tiagabine—Insomnia—Methotrexate—ankylosing spondylitis	0.000342	0.000729	CcSEcCtD
Tiagabine—Nausea—Triamcinolone—ankylosing spondylitis	0.00034	0.000725	CcSEcCtD
Tiagabine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000339	0.000724	CcSEcCtD
Tiagabine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000339	0.000724	CcSEcCtD
Tiagabine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000337	0.000719	CcSEcCtD
Tiagabine—Somnolence—Methotrexate—ankylosing spondylitis	0.000336	0.000717	CcSEcCtD
Tiagabine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000333	0.000711	CcSEcCtD
Tiagabine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000333	0.00071	CcSEcCtD
Tiagabine—Vomiting—Dexamethasone—ankylosing spondylitis	0.00033	0.000704	CcSEcCtD
Tiagabine—Vomiting—Betamethasone—ankylosing spondylitis	0.00033	0.000704	CcSEcCtD
Tiagabine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000329	0.000701	CcSEcCtD
Tiagabine—Rash—Dexamethasone—ankylosing spondylitis	0.000328	0.000699	CcSEcCtD
Tiagabine—Rash—Betamethasone—ankylosing spondylitis	0.000328	0.000699	CcSEcCtD
Tiagabine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000327	0.000698	CcSEcCtD
Tiagabine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000327	0.000698	CcSEcCtD
Tiagabine—Fatigue—Methotrexate—ankylosing spondylitis	0.000326	0.000695	CcSEcCtD
Tiagabine—Headache—Dexamethasone—ankylosing spondylitis	0.000325	0.000694	CcSEcCtD
Tiagabine—Headache—Betamethasone—ankylosing spondylitis	0.000325	0.000694	CcSEcCtD
Tiagabine—Asthenia—Prednisone—ankylosing spondylitis	0.000325	0.000692	CcSEcCtD
Tiagabine—Pain—Methotrexate—ankylosing spondylitis	0.000323	0.00069	CcSEcCtD
Tiagabine—Pruritus—Prednisone—ankylosing spondylitis	0.00032	0.000683	CcSEcCtD
Tiagabine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000312	0.000665	CcSEcCtD
Tiagabine—Diarrhoea—Prednisone—ankylosing spondylitis	0.00031	0.00066	CcSEcCtD
Tiagabine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000309	0.000659	CcSEcCtD
Tiagabine—Nausea—Dexamethasone—ankylosing spondylitis	0.000309	0.000658	CcSEcCtD
Tiagabine—Nausea—Betamethasone—ankylosing spondylitis	0.000309	0.000658	CcSEcCtD
Tiagabine—Urticaria—Methotrexate—ankylosing spondylitis	0.0003	0.000641	CcSEcCtD
Tiagabine—Dizziness—Prednisone—ankylosing spondylitis	0.000299	0.000638	CcSEcCtD
Tiagabine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000299	0.000637	CcSEcCtD
Tiagabine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000299	0.000637	CcSEcCtD
Tiagabine—Vomiting—Prednisone—ankylosing spondylitis	0.000288	0.000614	CcSEcCtD
Tiagabine—Rash—Prednisone—ankylosing spondylitis	0.000285	0.000608	CcSEcCtD
Tiagabine—Dermatitis—Prednisone—ankylosing spondylitis	0.000285	0.000608	CcSEcCtD
Tiagabine—Headache—Prednisone—ankylosing spondylitis	0.000283	0.000605	CcSEcCtD
Tiagabine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000279	0.000594	CcSEcCtD
Tiagabine—Asthenia—Methotrexate—ankylosing spondylitis	0.000271	0.000579	CcSEcCtD
Tiagabine—Nausea—Prednisone—ankylosing spondylitis	0.000269	0.000573	CcSEcCtD
Tiagabine—Pruritus—Methotrexate—ankylosing spondylitis	0.000267	0.000571	CcSEcCtD
Tiagabine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000259	0.000552	CcSEcCtD
Tiagabine—Dizziness—Methotrexate—ankylosing spondylitis	0.00025	0.000533	CcSEcCtD
Tiagabine—Vomiting—Methotrexate—ankylosing spondylitis	0.00024	0.000513	CcSEcCtD
Tiagabine—Rash—Methotrexate—ankylosing spondylitis	0.000238	0.000508	CcSEcCtD
Tiagabine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000238	0.000508	CcSEcCtD
Tiagabine—Headache—Methotrexate—ankylosing spondylitis	0.000237	0.000505	CcSEcCtD
Tiagabine—Nausea—Methotrexate—ankylosing spondylitis	0.000225	0.000479	CcSEcCtD
